Crawford Fund Management’s Novavax NVAX Stock Holding History

Crawford Fund Management’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-25,000	Closed	-$168K	–	210
2025 Q4	$168K	Hold	25,000	–	–	0.02%	190
2025 Q3	$217K	Hold	25,000	–	–	0.03%	182
2025 Q2	$158K	Sell	25,000 -11,000	-31%	-$72.8K	0.03%	185
2025 Q1	$231K	Sell	36,000 -29,900	-45%	-$247K	0.06%	167
2024 Q4	$530K	Buy	65,900 +15,900	+32%	+$153K	0.09%	165
2024 Q3	$632K	Sell	50,000 -51,000	-50%	-$659K	0.14%	131
2024 Q2	$1.28M	Sell	101,000 -3,000	-3%	-$30.2K	0.32%	83
2024 Q1	$497K	Buy	104,000 +97,000	+1,386%	+$450K	0.12%	135
2023 Q4	$33.6K	Buy	+7,000	New	+$42.8K	0.01%	239

Other funds holding NVAX

Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return

Bank of America

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return